Comparison of modern and conventional imaging techniques in establishing multiple myeloma‐related bone disease: a systematic review

Josien C. Regelink(Vrije Universiteit Amsterdam), Monique C. Minnema(University Medical Center Utrecht), Evangelos Terpos(National and Kapodistrian University of Athens), Marjolein H. Kamphuis(University Medical Center Utrecht), Pieter G. Raijmakers(Amsterdam UMC Location Vrije Universiteit Amsterdam), Indra C. Pieters van den Bos(Amsterdam UMC Location Vrije Universiteit Amsterdam), Ben G. F. Heggelman(Meander Medisch Centrum), Rutger‐Jan Nievelstein(University Medical Center Utrecht), René H.J. Otten(Amsterdam UMC Location Vrije Universiteit Amsterdam), Danielle van Lammeren – Venema(Haga Hospital), Josée M. Zijlstra(Vrije Universiteit Amsterdam), Anne I.J. Arens(Radboud University Nijmegen), Jacky W. de Rooy(Radboud University Nijmegen), Otto S. Hoekstra(Amsterdam UMC Location Vrije Universiteit Amsterdam), Reinier Raymakers(University Medical Center Utrecht), Pieter Sonneveld(Erasmus University Rotterdam), Raymond Ostelo(Amsterdam Public Health), Sonja Zweegman(Vrije Universiteit Amsterdam)
British Journal of Haematology
April 25, 2013
Cited by 211

Abstract

This systematic review of studies compared magnetic resonance imaging (MRI), (18) F-fluorodeoxyglucose positron emission tomography (FDG-PET), FDG-PET with computerized tomography (PET-CT) and CT with whole body X-Ray (WBXR) or (whole body) CT in order to provide evidence-based diagnostic guidelines in multiple myeloma bone disease. A comprehensive search of 3 bibliographic databases was performed; methodological quality was assessed using Quality Assessment of Diagnostic Accuracy Studies (QUADAS) criteria (score 1-14). Data from 32 directly comparative studies were extracted. The mean QUADAS score was 7·1 (3-11), with quality hampered mainly by a poor description of selection and execution criteria. All index tests had a higher detection rate when compared to WBXR, with up to 80% more lesions detected by the newer imaging techniques; MRI (1·12-1·82) CT (1·04-1·33), PET (1·00-1·58) and PET-CT (1·27-1·45). However, the modern imaging techniques detected fewer lesions in the skull and ribs. In a direct comparison CT and MRI performed equally with respect to detection rate and sensitivity. This systematic review supports the International Myeloma Working Group guidelines, which recommend that WBCT can replace WBXR. In our opinion, the equal performance of MRI also indicates that it is a valuable alternative. As lesions of the skull and ribs are underdiagnosed by modern imaging techniques we advise additional X-rays of these regions. The consequences of this approach are discussed.


Related Papers